Skip to content

Chest Compressor for Conservative Treatment of Pectus Carinatum: a Multicenter Study

Safety and Efficacy of a Modular and Adjustable Chest Compressor Model for Conservative Treatment of Pectus Carinatum: a Multicenter Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04171063
Enrollment
60
Registered
2019-11-20
Start date
2019-11-01
Completion date
2022-12-01
Last updated
2021-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pectus Carinatum, Chondromanubrial

Keywords

Braces, Conservative treatment, Thoracic wall, Pectus carinatum

Brief summary

Pectus carinatum (PC) is a congenital deformity of the chest wall whose prevalence is 0.6% of the population and although it does not cause cardio respiratory physiological damage, it has profound psychological effects on young people. Its treatment today is still primarily surgical in our country, despite the fact that conservative treatment by chest compression may be effective in the chondrogladiolar variant, which represents 90% of cases of PC. The aim of the present study is to conservatively treat a series of 60 patients using a new modular and adjustable chest compressor model to assess the effectiveness of this chest compressor in the noninvasive treatment of PC; and also assess the safety of such treatment by the rate of adverse events occurring during treatment. Secondary objectives will be to evaluate the adherence that PC patients have to this type of treatment by quantifying the number of hours of use per day, besides evaluating the chest compressor and its components for durability and resistance as a device for continuous use.

Interventions

DEVICEThoracic compressor

The intervention is the use of the thoracic compressor for the conservative treatment of pectus carinatum

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients will be allocated to use the thoracic compressor for 16 months

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Pectus carinatum condrogladiolar Variant * No other comorbidities that could interfere with the use of compressor

Exclusion criteria

* Marfan Syndrome * Active cardiovascular disease * Significant scoliosis or thoracic deformity * Important obesity * Pectus carinatum chondromanubrial variant * Poor commitment to protocol by both research participant and parents

Design outcomes

Primary

MeasureTime frameDescription
Treatment efficiency in repairing the pectus carinatum16 monthsThe anthroprometric measures in centimeters of the thoracic cage will be taken before and after the treatment to evaluate the effectiveness of the chest compressor in repairing the pectus carinatum
Treatment safety16 monthsThe adverse events that can possibly occur during treatment will be recorded in the patients using the chest compressor for pectus carinatum repair

Secondary

MeasureTime frameDescription
Treatment adherence16 monthsThe number of hours of daily use of the chest compressor will be recorded as a measurement of the level of adherence to the chest compressor treatment
Device durability16 monthsThe mechanic problems presented by the chest compressor as fractures, screw loosening or fastener break will be recorded as a durability and strength measure of the chest compressor and its components.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026